CC BY-NC-ND7.19 MB (download)
Communication about malaria areas and treatments is crucial so that people are aware of risks.
Articles on Malaria
Displaying 101 - 120 of 290 articles
An out-of-control COVID epidemic in PNG would be a humanitarian and economic disaster for the nation itself, and a grave threat to the region.
Southern African Development Community countries are very connected. Highly mobile and migrant populations frequently cross borders, posing significant challenges to reaching a malaria-free region.
Genetic diversity of a parasite population might help us watch for drug-resistant parasites.
This invasive mosquito thrives in the type of habitat commonly found in urban areas. This means that malaria could become more prevalent in African cities.
As ready as you are to be done with COVID-19, it’s not going anywhere soon. A historian of disease describes how once a pathogen emerges, it’s usually here to stay.
Malaria, tuberculosis and HIV/AIDS are regarded as the ‘big three’ infectious diseases. This is where scientists are at in their efforts to find a vaccine for each one.
A warming climate may change the types of viruses that thrive. A new report suggests that the threat of malaria may be replaced by dengue, for which there is no treatment and no cure.
We modelled surface water across Africa to show which parts of the continent are climatically-suitable for malaria – and how this will change.
With all the attention focussed on combating the spread of COVID-19 it’s easy to forget the other health challenges that could affect us all.
Gene drive guarantees that a trait will be passed to the next generation. But should society use this tool to control insect populations?
Currently, there is no evidence that this highly effective antimalarial can treat COVID-19 – and the threat of drug resistance should deter us from using it indiscriminately.
Yellow fever, malaria and Ebola all spilled over from animals to humans at the edges of tropical forests. The new coronavirus is the latest zoonosis.
Mosquitoes that had Microsporidia MB - a tiny parasitic fungus - never became infected with malaria.
The pandemic coincides with the long rainy season in Kenya. Rain increases mosquito breeding sites, vector density and thus transmission of mosquito-borne diseases.
The US president has reignited controversy over the use of malaria drugs to guard against COVID-19. But there is little reliable evidence so far that this tactic is safe or effective.
On this continent, a child dies from malaria every two minutes. This is an unacceptable reality for a treatable and preventable disease.
If not addressed, there will be many more deaths from malaria and other diseases, indirectly linked to COVID-19 disruptions.
With recent calls for their use in combating COVID-19, there are concerns that chloroquine and hydroxychloroquine might become unavailable to people who need them.
Some of the false claims about coronavirus may be harmless. But others can be potentially dangerous.
Top contributors
-
Principal Medical Scientist and Head of Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, National Institute for Communicable Diseases
-
Medical scientist, National Institute for Communicable Diseases
-
Medical Entomologist at the School of Biological Sciences, University of Nairobi
-
UP ISMC: Project Manager and Coordinator, University of Pretoria
-
Director: UP Institute for Sustainable Malaria Control, University of Pretoria
-
Chief Research Officer, Kenya Medical Research Institute
-
Director of the Jenner Institute, University of Oxford
-
Director of Science, Ifakara Health Institute
-
Project Manager, Cambridge Africa, Anglia Ruskin University
-
Professor of Molecular Parasitology and Medicine, St George's, University of London
-
Clinical Associate Professor, School of Medical Science & Sydney Infectious Diseases Institute; Principal Hospital Scientist, University of Sydney
-
Board Certified Internal Medicine Physician and Public Health Scientist, MidMichigan Health, University of Michigan
-
Director and CEO, Burnet Institute
-
Co-Director, Institute of Infection, Chair, Immunology & Vaccinology, Imperial College London
-
Scientist, International Centre of Insect Physiology and Ecology